EpiPulse Cases：2025年呼吸道病毒综合监测报告方案

Reporting Protocol 2025 forintegratedrespiratory virus surveillance, version 1.11 December2025 Contents How to use this document....................................................................................................................... 6Finding further information...................................................................................................................... 6Copyright............................................................................................................................................... 6Introduction........................................................................................................................................... 7Aim............................................................................................................................................. 7Objectives ................................................................................................................................... 7Record types ............................................................................................................................... 7Case definitions............................................................................................................................ 8Reporting to TESSy............................................................................................................................... 10When, what and how to report .................................................................................................... 10Preparing data ........................................................................................................................... 10Checking metadata..................................................................................................................... 10Submitting your data .................................................................................................................. 10Finalising your submission........................................................................................................... 11Navigating EpiPulse cases platform .............................................................................................. 11TESSy/EpiPulse Cases Help Desk ................................................................................................. 11Annex.................................................................................................................................................. 12Revisions of metadata sets.......................................................................................................... 12Current record type versions ....................................................................................................... 12RESPIAGGR metadata................................................................................................................. 13RESPISEVERE metadata.............................................................................................................. 18RESPISURV metadata ................................................................................................................. 23SARISURV metadata................................................................................................................... 38SARISURVDENOM metadata........................................................................................................ 54INFLSARIAGGR metadata............................................................................................................ 60INFLCLINAGGR metadata............................................................................................................ 77INFLANTIVIR metadata .............................................................................................................. 84NCOVVARIANT metadata ............................................................................................................ 95 Summary of changes to current metadata The following changes have been made to SARISURV: •12/12/2025: RSVVacProduct coded value list has been updated and expanded to includemonoclonal antibodies.•12/12/2025: Drug Used for Prophylaxis coded value list has been updated.•12/12/2025: BrandLastCOVID19Dose coded value list has been updated.•21/05/2025: Drug Used for Prophylaxis and Drug Used for Treatment coded value list hasbeen updated.•29/07/2024: KP.3 added to the coded value list for VirusVariantCOVID•08/03/2024: BrandLastCOVID19Dose coded value list has been updated.•07/12/2023: BrandLastCOVID19Dose coded value list has been updated.•27/11/2023: BA.2.86 added to the coded value list for VirusVariantCOVID•Precondition (repeatable variable with coded value list) and Complications (repeatablevariable with coded value list) have been added. The individual variables for preconditionsand complications have been removed: ASTH, CANC, CARDIACDIS, DIAB, HYPERT, HIV,IMMUNEOTH, IMMUNO, KIDNEY, LIVE